Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Osteoarthritis and Cartilage
|
May 7, 2008
Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes
I-G Sunk, D Demetriou, J Szendroedi, et al.
Antimicrobial Agents and Chemotherapy
|
September 16, 1998
Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration
F Thalhammer, P Schenk, H Burgmann, et al.
The International Journal of Artificial Organs
|
August 21, 2001
A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy
L Kramer, A Gendo, C Madl, et al.
Lancet (London, England)
|
December 5, 2009
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data
A Mehta, M Beck, P Elliott, et al.
Anesthesia and Analgesia
|
March 29, 2000
Safe and efficient emergency transvenous ventricular pacing via the right supraclavicular route
K Laczika, F Thalhammer, G Locker, et al.
European Journal of Clinical Investigation
|
March 18, 2004
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
A Mehta, R Ricci, U Widmer, et al.
Kidney International
|
June 2, 1998
Major determinants of hyperhomocysteinemia in peritoneal dialysis patients
A Vychytil, M Födinger, G Wölfl, et al.
European Journal of Clinical Investigation
|
December 21, 2004
Fabry disease: overall effects of agalsidase alfa treatment
M Beck, R Ricci, U Widmer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 29, 2001
Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients
A C Hauser, W Hagen, P H Rehak, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2016
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C H van der Wouden, A Cambon-Thomsen, E Cecchin, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Osteoarthritis and Cartilage
|
May 7, 2008
Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes
I-G Sunk, D Demetriou, J Szendroedi, et al.
Antimicrobial Agents and Chemotherapy
|
September 16, 1998
Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration
F Thalhammer, P Schenk, H Burgmann, et al.
The International Journal of Artificial Organs
|
August 21, 2001
A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy
L Kramer, A Gendo, C Madl, et al.
Lancet (London, England)
|
December 5, 2009
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data
A Mehta, M Beck, P Elliott, et al.
Anesthesia and Analgesia
|
March 29, 2000
Safe and efficient emergency transvenous ventricular pacing via the right supraclavicular route
K Laczika, F Thalhammer, G Locker, et al.
European Journal of Clinical Investigation
|
March 18, 2004
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
A Mehta, R Ricci, U Widmer, et al.
Kidney International
|
June 2, 1998
Major determinants of hyperhomocysteinemia in peritoneal dialysis patients
A Vychytil, M Födinger, G Wölfl, et al.
European Journal of Clinical Investigation
|
December 21, 2004
Fabry disease: overall effects of agalsidase alfa treatment
M Beck, R Ricci, U Widmer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 29, 2001
Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients
A C Hauser, W Hagen, P H Rehak, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2016
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C H van der Wouden, A Cambon-Thomsen, E Cecchin, et al.
Page
of 10